INCENDIA THERAPEUTICS Trademark

Trademark Overview


On Tuesday, December 12, 2023, a trademark application was filed for INCENDIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the INCENDIA THERAPEUTICS trademark a serial number of 98311415. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, January 22, 2025. This trademark is owned by Incendia Therapeutics Inc.. The INCENDIA THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

monoclonal antibody products and preparations for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical products and preparations consisting of monoclonal antibodies for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of immune-excluded tumors found in recalcitrant cancers

monoclonal antibodies used in industry and science, and in the manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the treatment of immune-excluded tumors found in recalcitrant cancers

drug discovery services for the discovery of monoclonal antibody-containing drugs, provided through a computational platform engine in the field of recalcitrant cancers
incendia therapeutics

General Information


Serial Number98311415
Word MarkINCENDIA THERAPEUTICS
Filing DateTuesday, December 12, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, January 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of three gradually thickening and lightening parallel lines forming a circular loop from right to left with the terminal ends converging into a upward facing point.
Goods and Servicesmonoclonal antibody products and preparations for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical products and preparations consisting of monoclonal antibodies for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of immune-excluded tumors found in recalcitrant cancers
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesmonoclonal antibodies used in industry and science, and in the manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the treatment of immune-excluded tumors found in recalcitrant cancers
NOT AVAILABLETHERAPEUTICS
Goods and Servicesdrug discovery services for the discovery of monoclonal antibody-containing drugs, provided through a computational platform engine in the field of recalcitrant cancers

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIncendia Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135

Trademark Events


Event DateEvent Description
Sunday, March 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 26, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 12, 2023NEW APPLICATION ENTERED
Thursday, July 11, 2024ASSIGNED TO EXAMINER
Friday, July 12, 2024NON-FINAL ACTION WRITTEN
Friday, July 12, 2024NON-FINAL ACTION E-MAILED
Friday, July 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 9, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, October 9, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, December 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 22, 2025FINAL REFUSAL E-MAILED
Wednesday, January 22, 2025FINAL REFUSAL WRITTEN
Wednesday, January 22, 2025NOTIFICATION OF FINAL REFUSAL EMAILED